Inovio Pharmaceuticals
INO
INO
130 hedge funds and large institutions have $182M invested in Inovio Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 47 increasing their positions, 29 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
3% more funds holding
Funds holding: 126 → 130 (+4)
0.33% more ownership
Funds ownership: 2.65% → 2.98% (+0.33%)
Holders
130
Holding in Top 10
–
Calls
$1.16M
Puts
$626K
Top Buyers
| 1 | +$11.3M | |
| 2 | +$4.02M | |
| 3 | +$2.36M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$2.22M |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$1.76M |
Top Sellers
| 1 | -$4.66M | |
| 2 | -$2.11M | |
| 3 | -$843K | |
| 4 |
Squarepoint
New York
|
-$716K |
| 5 |
Man Group
London,
United Kingdom
|
-$662K |